News | January 21, 2022
Biocon consolidated PAT at Rs 187.1 cr. in Q3FY22
Biocon has reported consolidated financial results for the period ended December 31, 2021
Biocon has reported consolidated financial results for the period ended December 31, 2021
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
It’s a two-dose vaccine administered 28 days apart
Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
The company plans to raise US $ 15 million
Subscribe To Our Newsletter & Stay Updated
